U.S. markets open in 5 hours 44 minutes
  • S&P Futures

    4,459.75
    +14.00 (+0.31%)
     
  • Dow Futures

    34,826.00
    +152.00 (+0.44%)
     
  • Nasdaq Futures

    15,356.00
    +37.25 (+0.24%)
     
  • Russell 2000 Futures

    2,255.50
    +11.50 (+0.51%)
     
  • Crude Oil

    74.84
    +0.86 (+1.16%)
     
  • Gold

    1,757.40
    +5.70 (+0.33%)
     
  • Silver

    22.62
    +0.20 (+0.89%)
     
  • EUR/USD

    1.1704
    -0.0014 (-0.12%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    17.83
    -0.80 (-4.29%)
     
  • GBP/USD

    1.3691
    +0.0010 (+0.07%)
     
  • USD/JPY

    110.6780
    -0.0070 (-0.01%)
     
  • BTC-USD

    43,825.16
    +2,523.90 (+6.11%)
     
  • CMC Crypto 200

    1,092.03
    -11.03 (-1.00%)
     
  • FTSE 100

    7,089.29
    +37.81 (+0.54%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

3 Things About Fulgent Genetics That Smart Investors Know

·4 min read
3 Things About Fulgent Genetics That Smart Investors Know
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

During the COVID-19 pandemic, Fulgent Genetics (NASDAQ: FLGT) was in the right place at the right time. Fulgent became a key provider of COVID-19 testing in 2020 and saw its revenue explode by almost 1,300% over the prior year. The good news is that Fulgent isn't a one-trick pony.